Kim, S., Kim, H., & Suh, H. (2016). PCN20 - Combination Therapy Of Braf Inhibitors For Advanced Melanoma With V600 Braf Mutation: A Systematic Review And Meta-Analysis. Value in Health, 19(3), A137. https://doi.org/10.1016/j.jval.2016.03.1642
Chicago Style (17th ed.) CitationKim, S., HT Kim, and HS Suh. "PCN20 - Combination Therapy Of Braf Inhibitors For Advanced Melanoma With V600 Braf Mutation: A Systematic Review And Meta-Analysis." Value in Health 19, no. 3 (2016): A137. https://doi.org/10.1016/j.jval.2016.03.1642.
MLA (9th ed.) CitationKim, S., et al. "PCN20 - Combination Therapy Of Braf Inhibitors For Advanced Melanoma With V600 Braf Mutation: A Systematic Review And Meta-Analysis." Value in Health, vol. 19, no. 3, 2016, p. A137, https://doi.org/10.1016/j.jval.2016.03.1642.